Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP665719.RATovYLNjKX_j4jPmG3ly8C4ueOjsMlv1GlvDmbA4TtJ0130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665719.RATovYLNjKX_j4jPmG3ly8C4ueOjsMlv1GlvDmbA4TtJ0130_provenance.
• NP665723.RAa51hn1vjVE-0IMNIbBdGDao8XUwufcnCfHMWvZhGzxg130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665723.RAa51hn1vjVE-0IMNIbBdGDao8XUwufcnCfHMWvZhGzxg130_provenance.
• NP665722.RAtLTdWDvTZk7nfk57n8rDSuUfLC8m5IACyihcJYeXI7U130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665722.RAtLTdWDvTZk7nfk57n8rDSuUfLC8m5IACyihcJYeXI7U130_provenance.
• NP665714.RAL2f9ExkRydnWCPxusGwMjHclZFA20LXGvWAYiRZNTv0130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665714.RAL2f9ExkRydnWCPxusGwMjHclZFA20LXGvWAYiRZNTv0130_provenance.
• NP665718.RAHQlYY9qbBL8oiyQmfeWNY-Vy2PEc-TmNjAKPrtnk4oc130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665718.RAHQlYY9qbBL8oiyQmfeWNY-Vy2PEc-TmNjAKPrtnk4oc130_provenance.
• NP665721.RAGyW_OVYW9-q068s3EfAe1yEk5CKh1rix_koiXxX5l4E130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665721.RAGyW_OVYW9-q068s3EfAe1yEk5CKh1rix_koiXxX5l4E130_provenance.
• NP665715.RAyX-o4SQSwaP8F6Gao5c-EVLOrdlj1f7am91ka97D-n4130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665715.RAyX-o4SQSwaP8F6Gao5c-EVLOrdlj1f7am91ka97D-n4130_provenance.
• NP665720.RA46NT-gJTsB_4MJ9h0uaSoA0oeAmFXy6p7DITHDiK33o130_assertion description "[Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (Leprechaunism), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665720.RA46NT-gJTsB_4MJ9h0uaSoA0oeAmFXy6p7DITHDiK33o130_provenance.